Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.51% is in line with its 5-year average of 59.58%, near the low end of its 5-year range (56.46%–66.63%).
2.75% below its 12-month average of 60.16%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-26): 57.64%.
GROSS MARGIN
58.51%
GROSS MARGIN AVG TTM
60.16%
GROSS MARGIN AVG 3Y
58.92%
GROSS MARGIN AVG 5Y
59.58%
GROSS MARGIN AVG 10Y
57.98%
GROSS MARGIN AVG 15Y
56.02%
GROSS MARGIN AVG 20Y
53.86%
CURRENT VS TTM AVG
-2.75%
CURRENT VS 3Y AVG
-0.70%
CURRENT VS 5Y AVG
-1.80%
CURRENT VS 10Y AVG
+0.92%
CURRENT VS 15Y AVG
+4.45%
CURRENT VS 20Y AVG
+8.63%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-0.82%
vs the sector median at left
Danaher Corporation
Market Cap
$146.14B
Gross Margin
58.51%
TTM Avg
60.16%
3Y Avg
58.92%
5Y Avg
59.58%
Market Cap
$135.34B
Gross Margin
66.68%
TTM Avg
66.73%
3Y Avg
66.82%
5Y Avg
67.04%
Market Cap
$130.61B
Gross Margin
70.16%
TTM Avg
63.94%
3Y Avg
60.40%
5Y Avg
58.39%
Market Cap
$130.75B
Gross Margin
86.04%
TTM Avg
85.57%
3Y Avg
86.56%
5Y Avg
87.08%
Market Cap
$178.09B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
Market Cap
$110.20B
Gross Margin
65.17%
TTM Avg
62.91%
3Y Avg
61.66%
5Y Avg
61.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $146.14B | 58.51% | 60.16% | 58.92% | 59.58% |
| Pfizer Inc. (PFE)vs › | $156.56B | 71.32% | 68.05% | 62.23% | 63.06% |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.34B | 66.68% | 66.73% | 66.82% | 67.04% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.61B | 70.16% | 63.94% | 60.40% | 58.39% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.75B | 86.04% | 85.57% | 86.56% | 87.08% |
| Medtronic plc (MDT)vs › | $120.45B | 66.69% | 65.17% | 65.34% | 65.75% |
| CVS Health Corp. (CVS)vs › | $119.49B | 14.15% | 13.78% | 14.92% | 15.96% |
| Abbott Laboratories (ABT)vs › | $178.09B | 56.80% | 53.17% | 51.86% | 51.92% |
| Stryker Corporation (SYK)vs › | $110.20B | 65.17% | 62.91% | 61.66% | 61.70% |
| Gilead Sciences, Inc. (GILD)vs › | $183.65B | 79.59% | 78.55% | 78.10% | 78.28% |
Gross Margin
58.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-26 | 57.64% |
| 2026-03-27 | 60.34% |
| 2025-12-31 | 58.00% |
| 2025-09-26 | 58.20% |
| 2025-06-27 | 66.63% |
| 2025-03-28 | 61.16% |
| 2024-12-31 | 59.50% |
| 2024-09-27 | 58.66% |
| 2024-06-28 | 59.69% |
| 2024-03-29 | 60.16% |
| 2023-12-31 | 59.00% |
| 2023-09-29 | 58.23% |
| 2023-06-30 | 56.46% |
| 2023-03-31 | 61.56% |
| 2022-12-31 | 59.24% |
| 2022-09-30 | 59.82% |
| 2022-07-01 | 60.91% |
| 2022-04-01 | 61.20% |
| 2021-12-31 | 60.67% |
| 2021-10-01 | 60.30% |
| 2021-07-02 | 60.92% |
| 2021-04-02 | 62.02% |
| 2020-12-31 | 58.49% |
| 2020-10-02 | 54.83% |
| 2020-07-03 | 53.85% |
| 2020-04-03 | 56.25% |
| 2019-12-31 | 55.53% |
| 2019-09-27 | 55.77% |
| 2019-06-28 | 55.88% |
| 2019-03-29 | 55.80% |
| 2018-12-31 | 55.03% |
| 2018-09-28 | 55.44% |
| 2018-06-29 | 56.56% |
| 2018-03-30 | 56.30% |
| 2017-12-31 | 55.83% |
| 2017-09-29 | 56.02% |
| 2017-06-30 | 55.50% |
| 2017-03-31 | 55.50% |
| 2016-12-31 | 54.53% |
| 2016-09-30 | 55.32% |
| 2016-07-01 | 54.44% |
| 2016-04-01 | 53.14% |
| 2015-12-31 | 51.20% |
| 2015-10-02 | 52.49% |
| 2015-07-03 | 53.84% |
| 2015-04-03 | 53.35% |
| 2014-12-31 | 51.76% |
| 2014-09-26 | 52.68% |
| 2014-06-27 | 52.79% |
| 2014-03-28 | 52.61% |
| 2013-12-31 | 51.49% |
| 2013-09-27 | 51.93% |
| 2013-06-28 | 52.68% |
| 2013-03-29 | 52.33% |
| 2012-12-31 | 51.16% |
| 2012-09-28 | 51.59% |
| 2012-06-29 | 51.73% |
| 2012-03-30 | 51.79% |
| 2011-12-31 | 50.17% |
| 2011-09-30 | 48.80% |
| 2011-07-01 | 52.35% |
| 2011-04-01 | 52.71% |
| 2010-12-31 | 50.99% |
| 2010-10-01 | 51.69% |
| 2010-07-02 | 49.52% |
| 2010-04-02 | 48.45% |
| 2009-12-31 | 45.91% |
| 2009-10-02 | 48.02% |
| 2009-07-03 | 47.21% |
| 2009-04-03 | 47.90% |
| 2008-12-31 | 45.70% |
| 2008-09-26 | 47.08% |
| 2008-06-27 | 47.51% |
| 2008-03-28 | 46.81% |
| 2007-12-31 | 46.18% |
| 2007-09-28 | 45.74% |
| 2007-06-29 | 45.49% |
| 2007-03-30 | 45.09% |
| 2006-12-31 | 44.84% |
| 2006-09-29 | 45.10% |
| 2006-06-30 | 43.92% |
| 2006-03-31 | 42.76% |
| 2005-12-31 | 42.95% |
| 2005-09-30 | 43.12% |
| 2005-07-01 | 44.05% |
| 2005-04-01 | 42.45% |
| 2004-12-31 | 42.22% |
| 2004-10-01 | 42.40% |
| 2004-07-02 | 42.30% |
| 2004-04-02 | 40.91% |
| 2003-12-31 | 40.59% |
| 2003-09-26 | 41.43% |
| 2003-06-27 | 40.39% |
| 2003-03-28 | 39.07% |
| 2002-12-31 | 39.65% |
| 2002-09-27 | 39.95% |
